{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:21:21Z","timestamp":1787678481299,"version":"build-2784847793"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110112","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:28:57Z","timestamp":1781566137000},"page":"110112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of new thiazolyl hydrazone derivatives as anti-breast cancer agents: Synthesis, biological evaluation and in silico studies"],"prefix":"10.1016","volume":"180","author":[{"given":"Fatih","family":"Tok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal Kabaday\u0131","family":"Ensario\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faika","family":"Ba\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"Becer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadire","family":"K\u0131yak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafize Seda","family":"Vatansever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.110112_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110112_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110112_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.bioorg.2026.110112_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110954","article-title":"Thiazolyl-isatin derivatives: synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins","volume":"394","author":"Freitas","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110112_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110112_bb0030","doi-asserted-by":"crossref","first-page":"S1040","DOI":"10.1016\/S2221-1691(12)60358-X","article-title":"Synthesis, molecular docking and biological evaluation of 4-cycloalkylidineamino 1,2-naphthoquinone semicarbazones as anticancer agents","volume":"2","author":"Shukla","year":"2012","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.bioorg.2026.110112_bb0035","doi-asserted-by":"crossref","first-page":"41944","DOI":"10.1021\/acsomega.4c06889","article-title":"Synthesis and evaluation of thiazolyl-indole-2-carboxamide derivatives as potent multitarget anticancer agents","volume":"9","author":"Saadan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110112_bb0040","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1016\/j.bmcl.2017.06.043","article-title":"Synthesis, antioxidant, antifungal, molecular docking and ADMET studies of some thiazolyl hydrazones","volume":"27","author":"Kauthale","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110112_bb0045","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/slct.201904770","article-title":"Synthesis and biological studies of some new thiazoles, hydrazones and azine derivatives based on 3,5-Diphenylcyclohex-2-en-1-one","volume":"5","author":"Abdel-Galil","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110112_bb0050","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s00044-019-02343-3","article-title":"Design, synthesis, bioactivity, and DFT calculation of 2-thiazolyl-hydrazone derivatives as influenza neuraminidase inhibitors","volume":"28","author":"Cui","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110112_bb0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/1570180815666180816124102","article-title":"Synthesis and anticancer activity of new hydrazide-hydrazones and their pd(II) complexes","volume":"16","author":"Kocyigit-Kaymakcioglu","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.bioorg.2026.110112_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200265","article-title":"N-substituted arylidene-3-(methylsulfonyl)-2-oxoimidazolidine-1-carbohydrazide as cholinesterase inhibitors: design, synthesis, and molecular docking study","volume":"19","author":"Tok","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2026.110112_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115452","article-title":"Thiazolyl hydrazineylidenyl indolones as unique potential multitargeting broad-spectrum antimicrobial agents","volume":"256","author":"Zhao","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0070","doi-asserted-by":"crossref","first-page":"863","DOI":"10.17344\/acsi.2022.7614","article-title":"Synthesis and biological evaluation of some hydrazide-hydrazone derivatives as anticancer agents","volume":"69","author":"Akda\u011f","year":"2022","journal-title":"Acta Chim. Slov."},{"key":"10.1016\/j.bioorg.2026.110112_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.135745","article-title":"Synthesis and evaluation of the antioxidant and anti-tyrosinase activities of thiazolyl hydrazone derivatives and their application in the anti-browning of fresh-cut potato","volume":"414","author":"Djafarou","year":"2023","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00397911.2019.1692870","article-title":"Synthesis, anticancer and antimicrobial evaluation of new pyridyl and thiazolyl clubbed hydrazone scaffolds","volume":"50","author":"Muluk","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.110112_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114097","article-title":"Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors","volume":"229","author":"Evren","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.taap.2017.06.003","article-title":"Anti-liver cancer activity in vitro and in vivo induced by 2-pyridyl 2,3-thiazole derivatives","volume":"329","author":"Silva","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110112_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200076","article-title":"Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl-hydrazone derivatives as histone lysine acetyl-transferase inhibitors and apoptosis inducers","volume":"355","author":"Abbas","year":"2022","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2026.110112_bb0100","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2174\/1570180814666161104161711","article-title":"Synthesis and evaluation of new thiazolyl hydrazone derivatives as potential anticancer agents","volume":"14","author":"Kaplanc\u0131kl\u0131","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110112_bb0105","doi-asserted-by":"crossref","first-page":"14809","DOI":"10.3390\/molecules190914809","article-title":"Synthesis and in vitro evaluation of new nitro-substituted thiazolyl hydrazone derivatives as anticandidal and anticancer agents","volume":"19","author":"Alt\u0131ntop","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110112_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/joch\/8938074","article-title":"New horizon and advancements in synthetic and biological applications of active methylene acetonitrile: Mini-review","volume":"2025","author":"Nagamalla","year":"2025","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0115","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-025-11306-3","article-title":"A perspective on the synthetic methodologies and biological attributes of thiazole-hydrazone compounds: a medicinal chemistry-based investigation","author":"Bhukta","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.110112_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2026.146091","article-title":"Spirocyclic butenolides with p-fluorophenylthiazolylhydrazone groups: structural analysis through NMR, crystal diffraction and DFT calculation","volume":"1366","author":"Zhang","year":"2026","journal-title":"J. Mol. Struct."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110112_bb0125","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1080\/00397911.2020.1854787","article-title":"Review of the synthesis and biological activity of thiazoles","volume":"51","author":"Ali","year":"2021","journal-title":"Synth. Commun."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110112_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70116","article-title":"Targeting lung Cancer: synthesis, characterization, enzyme inhibition, and antiproliferative activity of 1H-benzo[f]chromen-1-one-thiosemicarbazones supported by molecular docking","volume":"358","author":"Raza","year":"2025","journal-title":"Arch Pharm (Weinheim)."},{"key":"10.1016\/j.bioorg.2026.110112_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140702","article-title":"Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: synthesis, characterization and in vitro & in silico biological activity studies","volume":"1322","author":"\u00c7ak\u0131r","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110112_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202301089","article-title":"Synthesis and anticancer activity of novel derivatives of \u03b1,\u03b2-unsaturated ketones based on oleanolic acid: in vitro and in silico studies against prostate cancer cells","volume":"20","author":"\u015eenol","year":"2023","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2026.110112_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.143637","article-title":"Synthesis, biological evaluation, molecular docking and MD simulation studies of some new picolinohydrazide derivatives as cholinesterase inhibitors","volume":"1349","author":"Ku\u015ftan","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110112_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136903","article-title":"Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors","volume":"1296","author":"Demiraran","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110112_bb0155","first-page":"34","article-title":"Anticancer activities of thiosemicarbazides\/thiosemicarbazones: a review","volume":"6","author":"Arora","year":"2014","journal-title":"Int J Pharm Pharm Sci"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110112_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14355","article-title":"A newly synthesized thiosemicarbazide derivative trigger apoptosis rather than necroptosis on HEPG2 cell line","volume":"103","author":"Ba\u015fo\u011flu-\u00dcnal","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110112_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10426507.2022.2136665","article-title":"Synthesis and biological evaluation of thiazole and thiadiazole derivatives as potential anticancer agents","volume":"198","author":"Ekrek","year":"2022","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110112_bb0170","doi-asserted-by":"crossref","first-page":"783","DOI":"10.33808\/clinexphealthsci.1414252","article-title":"Novel thiazole-hydrazide derivatives and their anticancer properties","volume":"14","author":"Evren","year":"2024","journal-title":"Clin. Exp. Health Sci."},{"key":"10.1016\/j.bioorg.2026.110112_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105684","article-title":"Novel sulfonyl thiazolyl-hydrazone derivatives as EGFR inhibitors: design, synthesis, biological evaluation and molecular docking studies","volume":"121","author":"Farghaly","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137488","article-title":"Design, synthesis and molecular modeling studies of thiosemicarbazide & thiazolyl-hydrazone derivatives as potential anticancer agents and topoisomerase inhibitors","volume":"1302","author":"\u015eenkarde\u015f","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110112_bb0185","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2174\/1871520616666160219160256","article-title":"Macromolecular drug targets in cancer treatment and thiosemicarbazides as anticancer agents","volume":"16","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"2016","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104947","article-title":"Discovery of thieno[2,3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents","volume":"112","author":"El-Metwally","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0195","article-title":"Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors","volume":"355","author":"El-Adl","year":"2022","journal-title":"Arch. Pharm."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110112_bb0200","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/encyclopedia2040111","article-title":"Apoptosis regulators bcl-2 and caspase-3","volume":"2","author":"Hussar","year":"2022","journal-title":"Encyclopedia"},{"issue":"17","key":"10.1016\/j.bioorg.2026.110112_bb0205","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.3390\/cancers13174455","article-title":"Ki-67 as a prognostic biomarker in invasive breast cancer","volume":"13","author":"Davey","year":"2021","journal-title":"Cancers"},{"key":"#cr-split#-10.1016\/j.bioorg.2026.110112_bb0210.1","doi-asserted-by":"crossref","unstructured":"A. Najafov, H. Chen, J. Yuan, (2017). Necroptosis and cancer. Trends Cancer 3","DOI":"10.1016\/j.trecan.2017.03.002"},{"key":"#cr-split#-10.1016\/j.bioorg.2026.110112_bb0210.2","doi-asserted-by":"crossref","unstructured":"(4) (2017) 294-301. doi:https:\/\/doi.org\/10.1016\/j.trecan.2017.03.002.","DOI":"10.1016\/j.trecan.2017.03.002"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110112_bb0215","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/00397911.2025.2568472","article-title":"Dual action of novel 5-nitroguaiacol-based hydrazones: targeting aldolase-a and inducing apoptosis in lung cancer","volume":"55","author":"T\u00fcmenci","year":"2025","journal-title":"Synth. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110112_bb0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/cbdd.13896","article-title":"Novel imidazo [2,1-b] thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: synthesis, in silico and in vitro evaluation","volume":"98","author":"Ba\u015fo\u011flu","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110112_bb0225","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm060522a","article-title":"Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring","volume":"49","author":"Lyne","year":"2006","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110112_bb0230","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s12010-018-2863-7","article-title":"Probing gallate-mediated selectivity and high-affinity binding of epigallocatechin gallate: a way-forward in the design of selective inhibitors for anti-apoptotic Bcl-2 proteins","volume":"187","author":"Olotu","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110112_bb0235","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1039\/D2MD00116K","article-title":"Piperazine tethered bergenin heterocyclic hybrids: design, synthesis, anticancer activity, and molecular docking studies","volume":"13","author":"Rao","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108741","article-title":"New thiazine derivatives with dual potential for lipoxygenase inhibition and hemolytic activity: synthesis, characterization and molecular docking studies","volume":"120","author":"Khan","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110112_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144177","article-title":"Discovery and optimization of a novel series of pyrazole-linked oxadiazole conjugates as \u03b1-amylase inhibitors: in-silico DFT, ADMET-prediction, toxicological assessment and molecular docking insight","volume":"1351","author":"Sarfraz","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110112_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70166","article-title":"Synthesis, biological evaluation and molecular docking studies of new 4-(cyanomethyl)-N\u2019-substituted Benzohydrazide derivatives as anti-Alzheimer agents","volume":"86","author":"Tok","year":"2025","journal-title":"Drug Develop. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110112_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ph19020224","article-title":"Design, synthesis, biological evaluation and molecular docking studies of new N-heterocyclic compounds as aromatase inhibitors","volume":"19","author":"Tok","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110112_bb0260","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1007\/s00210-025-04879-1","article-title":"Design, synthesis and biological profiling of bis-thiazole linked Schiff bases as effective enzyme inhibitors for targeting urease and thymidine phosphorylase proteins","volume":"399","author":"Khan","year":"2026","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110112_bb0265","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/acs.jmedchem.8b01925","article-title":"Electrostatic complementarity as a fast and effective tool to optimize binding and selectivity of protein-ligand complexes","volume":"62","author":"Bauer","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110112_bb0270","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1021\/ci050357s","article-title":"Molecular field Extrema as descriptors of biological activity: definition and validation","volume":"46","author":"Cheeseright","year":"2006","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110112_bb0275","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1021\/acs.jcim.0c00165","article-title":"Assessment of binding affinity via alchemical free-energy calculations","volume":"60","author":"Kuhn","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.110112_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005659","article-title":"OpenMM 7: rapid development of high performance algorithms for molecular dynamics","volume":"13","author":"Eastman","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bioorg.2026.110112_bb0285","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:32:03Z","timestamp":1787675523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"alternative-id":["S0045206826006486"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110112","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of new thiazolyl hydrazone derivatives as anti-breast cancer agents: Synthesis, biological evaluation and in silico studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110112"}}